CLINICAL_TRIALS
trial_result
· 2018-11-13
Clinical Trial Update: Study of Tarceva and Targretin in Stage I-II Lung Cancer [NA]
Summary
A completed clinical trial evaluating Tarceva and Targretin for stage I-II non-small cell lung cancer with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Carcinoma, Non-small-cell Lung | NA | Status: COMPLETED | Results posted: 2018-11-13